Cargando…

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets

Improving the long-term prognosis of ulcerative colitis (UC) requires sustained deep mucosal colonic healing with histologic remission, making the study of colonic tissue regeneration essential. In experimental colitis models, lipid metabolites are recognized as pivotal components of this process. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bjerrum, Jacob Tveiten, Wang, Yulan, Zhang, Jingtao, Riis, Lene Buhl, Nielsen, Ole Haagen, Seidelin, Jakob Benedict
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935238/ https://www.ncbi.nlm.nih.gov/pubmed/35342362 http://dx.doi.org/10.7150/ijbs.67112

Ejemplares similares

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans
por: Seidelin, Jakob Benedict, et al.
Publicado: (2021)

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2013)

COX-2–PGE(2) Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis
por: Li, Yuan, et al.
Publicado: (2018)

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2014)

Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
por: Attauabi, Mohamed, et al.
Publicado: (2023)

Metabonomics in Gastroenterology and Hepatology
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2019)

Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
por: Olaisen, Maya, et al.
Publicado: (2019)

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?
por: Kjærgaard, Sebastian, et al.
Publicado: (2020)

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis
por: James, Jaslin Pallikkunnath, et al.
Publicado: (2023)

Mucosal microRNAs relate to age and severity of disease in ulcerative colitis
por: Malham, Mikkel, et al.
Publicado: (2021)

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD
por: Soendergaard, Christoffer, et al.
Publicado: (2018)

Identification of TNF-α-Responsive Promoters and Enhancers in the Intestinal Epithelial Cell Model Caco-2
por: Boyd, Mette, et al.
Publicado: (2014)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Evidence for Impaired CARD15 Signalling in Crohn's Disease without Disease Linked Variants
por: Seidelin, Jakob Benedict, et al.
Publicado: (2009)

IBD metabonomics predicts phenotype, disease course, and treatment response
por: Bjerrum, Jacob T., et al.
Publicado: (2021)

A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis
por: Honzawa, Yusuke, et al.
Publicado: (2020)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Impact of T300A Variant of ATG16L1 on Antibacterial Response, Risk of Culture Positive Infections, and Clinical Course of Crohn's Disease
por: Salem, Mohammad, et al.
Publicado: (2015)

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2009)

Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study
por: Häuser, Winfried, et al.
Publicado: (2005)

Decreased number of colonic tuft cells in quiescent ulcerative colitis patients
por: Kjærgaard, Sebastian, et al.
Publicado: (2020)

Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
por: Kitae, Hiroaki, et al.
Publicado: (2022)

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2017)

Oral Bran in Patients With Quiescent Ulcerative Colitis: Another Piece in the Diet Puzzle
por: El-Matary, Wael
Publicado: (2020)

Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018)

pcaGoPromoter - An R Package for Biological and Regulatory Interpretation of Principal Components in Genome-Wide Gene Expression Data
por: Hansen, Morten, et al.
Publicado: (2012)

Caloric restriction causes a distinct reorganization of the lipidome in quiescent and non-quiescent cells of budding yeast
por: Mohammad, Karamat, et al.
Publicado: (2021)

LIAISON(®) Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study
por: Fiorino, Gionata, et al.
Publicado: (2022)

Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis
por: Soendergaard, Christoffer, et al.
Publicado: (2017)

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
por: Démaris, Alix, et al.
Publicado: (2022)

Dietary iron does not impact the quality of life of patients with quiescent ulcerative colitis: an observational study
por: Tolkien, Zoe, et al.
Publicado: (2013)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis
por: Sasanuma, Seiko, et al.
Publicado: (2018)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Artificial intelligence‐assisted endoscopy changes the definition of mucosal healing in ulcerative colitis
por: Nakase, Hiroshi, et al.
Publicado: (2020)

Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis
por: Maeda, Keiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_72m03qtbhh9gchlmqkrt1gvttm